SBIR/STTR Research Award
Feasibility Study of the ACT (Active Cancellation of Tremor) Device
Award amount
$159,260Program and phase
SBIR · Phase IAward year
2010Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- LYNX DESIGN
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- PHS2010-2
- Topic code
- NINDS
Research abstract
DESCRIPTION (provided by applicant): Essential Tremor (ET) is the single most common motion disorder, affecting 10 million people in the US alone. Due to the debilitating muscle movements associated with this disease, people with ET have difficulty in performing daily functions such as eating and drinking and as a result often become socially isolated. Many individuals are also forced to retire from their occupations. Unfortunately, current pharmacological treatments have limited effectiveness in abating the condition, and surgical procedures can be expensive and invasive. To fill the needs of those who suffer from persistent tremor, Lynx Design is investigating a cost-effective, lightweight, hand-held stabilization device. In Phase I, Lynx Design proposes to develop a state-of-the-art actuator/controller system for a hand-held ACT (Active Cancellation of Tremor) device, and to demonstrate feasibility in a proof-of-concept prototype. Lynx Design will evaluate three possible actuator technologies- shape memory alloys, piezoelectrics, and electromagnetic actuators-and experimentally characterize the one found to be most suitable for the application. Lynx Design will then model, design, and build a prototype synthesizing this actuator with an embedded sensor and micro-controller to form a closed-loop system with the capability to stabilize ET. To demonstrate product feasibility, the resulting miniature actuator, sensor, and controller will be incorporated in a hand-held proof-of-concept device. Phase II work will focus on refining the ACT technology with patient input to create a commercial product. At the end of Phase II, Lynx Design will be ready to launch this highly portable, handheld product into the growing assistive device market, providing a far- reaching solution that positively impacts quality of life for a growing population of ET sufferers. ) PUBLIC HEALTH RELEVANCE: Lynx Design proposes to develop an active tremor cancellation technology that will assist individuals affected by Stroke or motion disorders such as Essential Tremor. It is Lynx Design's hope that these devices will reduce potential for social isolation, improve quality of life, and re-enable the affected public to participate in occupations that were lost upon disease onset.
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Enhancing Healthcare Delivery and Patient Outcomes: Noninvasive Wireless Sensors to Improve Ventricular Shunt Monitoring, Reduce Imaging, and Alleviate the Burden on Providers, Patients, and Families
- Commercialization Readiness Pilot for Flow Acceleration for Stroke Thrombolysis (FAST) System
- 3D in vitro model of genetic and sporadic FTD: accelerating novel therapeutic development
- Tacrolimus-eluting nerve guidance conduit for enhanced regeneration in critical-sized peripheral nerve injuries
- Promoting tissue repair and functional recovery after spinal cord injury by targeting the microtubule regulatory protein Fidgetin-like 2: Supplement for Imaging System